COVID-19

All of Us aims to collect and study health data from at least a million people in the U.S. to advance precision medicine. The program's CEO, Josh Denny discusses the role of electronic health records, how the program protects participant privacy and, most recently, how the program is pivoting efforts to make discoveries about COVID-19....

COVID-19 vaccine development presents an opportunity to break down barriers to the engagement of Black and Latinx individuals in clinical trials research. Ideally, vaccine trials should include participants from communities that have the highest risk of infection. In the case of COVID-19, those at-risk communities are disproportionately Black and Latinx....

The hope is that these and other findings yet to come will point the way to a more thorough understanding of the biology of COVID-19. They also suggest that a genetic test and a person’s blood type might provide useful tools for identifying those who may be at greater risk of serious illness....